Israeli Hospital Partners With National Institutes of Health to Study and Combat COVID-19
Last April, the Sheba Medical Center at Tel Hashomer, located near Tel Aviv, announced the signing of an “emergency agreement” with the Maryland-based National Institutes of Health (NIH) to conduct applied scientific and clinical research studies in order to develop coronavirus-related treatments.
The hospital committed to supplying the NIH’s Vaccine Research Center with blood samples, plasma and the COVID-19 virus itself from infected patients in Israel. This was all made possible due to a series of clinical trials the hospital was conducting on possible treatments, including those being developed by major pharmaceutical companies.